Other evidence suggests that the influence of insulin on tumor formation has effects in the early stages of cancer, as hyperinsulinemia is independently associated with benign proliferative breast disease [180], and insulin resistance is a risk factor for progressing from Barrett's esophagus to esophageal adenocarcinoma [181]. Here, INS is linked to esophageal adenocarcinoma.